AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
10.73
-0.03 (-0.28%)
Sep 3, 2026, 1:48 PM EDT - Market open
AVITA Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 75.63 | 71.61 | 64.25 | 50.14 | 34.42 | 33.03 |
Revenue Growth | 1.00% | 11.45% | 28.14% | 45.68% | 4.23% | 12.98% |
Gross Profit Gross Profit Growth | 61.68 | 58.82 | 55.16 | 42.36 | 28.38 | 26.92 |
Operating Income Operating Income Growth | -35.22 | -42.53 | -56.59 | -42.66 | -27.51 | -25.08 |
Net Income Net Income Growth | -43.08 | -48.59 | -61.85 | -35.38 | -26.67 | -25.14 |
Earnings Per Share EPS Growth | -1.44 | -1.74 | -2.39 | -1.40 | -1.07 | -1.03 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 72.55 | 68.79 | 62.16 | 46.36 | 33.26 | 32.73 |
Japan Japan Growth | 1.85 | 2.09 | 1.43 | 3.37 | 0.73 | - |
European Union European Union Growth | 0.32 | 0.05 | 0.16 | 0.05 | - | - |
Australia Australia Growth | 0.35 | 0.2 | 0.31 | 0.22 | 0.28 | 0.21 |
United Kingdom United Kingdom Growth | 0.56 | 0.49 | 0.2 | 0.14 | 0.16 | 0.09 |
Total Total Growth | 75.63 | 71.61 | 64.25 | 50.14 | 34.42 | 33.03 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 11.14 | 18.19 | 35.89 | 89.06 | 86.27 | 104.85 |
Total Debt Total Debt Growth | 48.48 | 46.05 | 45.99 | 42.41 | 0.92 | 1.64 |
Net Cash (Debt) Net Cash Growth | -37.35 | -27.86 | -10.1 | 46.65 | 85.35 | 103.21 |
Net Cash Growth | - | - | - | -45.35% | -17.30% | -5.45% |
Net Cash Per Share Net Cash Per Share Growth | -1.25 | -1.00 | -0.39 | 1.84 | 3.41 | 4.24 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -24.23 | -31.2 | -48.94 | -38.01 | -19.09 | -18.04 |
Capital Expenditures CapEx Growth | -0.39 | -1.01 | -9.17 | -1.38 | -0.45 | -0.49 |
Free Cash Flow Free Cash Flow Growth | -24.61 | -32.2 | -58.11 | -39.39 | -19.54 | -18.52 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 81.56% | 82.13% | 85.85% | 84.48% | 82.45% | 81.52% |
Operating Margin | -46.56% | -59.40% | -88.08% | -85.07% | -79.91% | -75.93% |
Pretax Margin | -56.94% | -67.83% | -96.17% | -70.43% | -77.36% | -76.00% |
Profit Margin | -56.96% | -67.85% | -96.25% | -70.56% | -77.47% | -76.13% |
FCF Margin | -32.54% | -44.97% | -90.44% | -78.56% | -56.77% | -56.09% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 4.42 | 1.48 | 5.26 | 7.03 | 4.83 | 9.04 |